nach oben

Reactions Weekly

Erschienen in:

01.01.2018 | Case report

Ceritinib

Interstitial pneumonitis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Auszug

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Joshi AP, et al. Ceritinib in anaplastic lymphoma kinase-positive nonsmall cell lung cancer among patients who were previously exposed to crizotinib: Experience from the Indian subcontinent. Indian Journal of Cancer 54: 144-147, No. 1, 2017. Available from: URL: http://doi.org/10.4103/ijc.IJC_186_17 - IndiaCrossRefPubMed

Titel: Ceritinib
Interstitial pneumonitis: case report
Publikationsdatum: 01.01.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-40678-x

Dabigatran etexilate/rivaroxaban

Case report

US FDA issues warning against unapproved stem cell therapy

News item

Ciprofloxacin/cefepime

Case report

Terlipressin

Case report

Apixaban overdose

Case report

Colecalciferol overdose

Case report

Springer Medizin

Ceritinib

Interstitial pneumonitis: case report

Auszug

Weitere Artikel der Ausgabe 1/2018

Dabigatran etexilate/rivaroxaban

US FDA issues warning against unapproved stem cell therapy

Ciprofloxacin/cefepime

Terlipressin

Apixaban overdose

Colecalciferol overdose

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Dabigatran etexilate/rivaroxaban

US FDA issues warning against unapproved stem cell therapy

Ciprofloxacin/cefepime

Terlipressin

Apixaban overdose

Colecalciferol overdose